Request for Covid-19 Impact Assessment of this Report
The United States 7-Valent Pneumococcal Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global 7-Valent Pneumococcal Vaccine market, reaching US$ million by the year 2028. As for the Europe 7-Valent Pneumococcal Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main 7-Valent Pneumococcal Vaccine players cover Merck, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of 7-Valent Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Single Dose Vial
Pre-filled Syringe
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 7-Valent Pneumococcal Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for 7-Valent Pneumococcal Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for 7-Valent Pneumococcal Vaccine by Country/Region, 2017, 2022 & 2028
2.2 7-Valent Pneumococcal Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 7-Valent Pneumococcal Vaccine Sales by Type
2.3.1 Global 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global 7-Valent Pneumococcal Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global 7-Valent Pneumococcal Vaccine Sale Price by Type (2017-2022)
2.4 7-Valent Pneumococcal Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 7-Valent Pneumococcal Vaccine Sales by Application
2.5.1 Global 7-Valent Pneumococcal Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global 7-Valent Pneumococcal Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global 7-Valent Pneumococcal Vaccine Sale Price by Application (2017-2022)
3 Global 7-Valent Pneumococcal Vaccine by Company
3.1 Global 7-Valent Pneumococcal Vaccine Breakdown Data by Company
3.1.1 Global 7-Valent Pneumococcal Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global 7-Valent Pneumococcal Vaccine Sales Market Share by Company (2020-2022)
3.2 Global 7-Valent Pneumococcal Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global 7-Valent Pneumococcal Vaccine Revenue by Company (2020-2022)
3.2.2 Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global 7-Valent Pneumococcal Vaccine Sale Price by Company
3.4 Key Manufacturers 7-Valent Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 7-Valent Pneumococcal Vaccine Product Location Distribution
3.4.2 Players 7-Valent Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for 7-Valent Pneumococcal Vaccine by Geographic Region
4.1 World Historic 7-Valent Pneumococcal Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global 7-Valent Pneumococcal Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global 7-Valent Pneumococcal Vaccine Annual Revenue by Geographic Region
4.2 World Historic 7-Valent Pneumococcal Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global 7-Valent Pneumococcal Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global 7-Valent Pneumococcal Vaccine Annual Revenue by Country/Region
4.3 Americas 7-Valent Pneumococcal Vaccine Sales Growth
4.4 APAC 7-Valent Pneumococcal Vaccine Sales Growth
4.5 Europe 7-Valent Pneumococcal Vaccine Sales Growth
4.6 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Growth
5 Americas
5.1 Americas 7-Valent Pneumococcal Vaccine Sales by Country
5.1.1 Americas 7-Valent Pneumococcal Vaccine Sales by Country (2017-2022)
5.1.2 Americas 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2022)
5.2 Americas 7-Valent Pneumococcal Vaccine Sales by Type
5.3 Americas 7-Valent Pneumococcal Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 7-Valent Pneumococcal Vaccine Sales by Region
6.1.1 APAC 7-Valent Pneumococcal Vaccine Sales by Region (2017-2022)
6.1.2 APAC 7-Valent Pneumococcal Vaccine Revenue by Region (2017-2022)
6.2 APAC 7-Valent Pneumococcal Vaccine Sales by Type
6.3 APAC 7-Valent Pneumococcal Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 7-Valent Pneumococcal Vaccine by Country
7.1.1 Europe 7-Valent Pneumococcal Vaccine Sales by Country (2017-2022)
7.1.2 Europe 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2022)
7.2 Europe 7-Valent Pneumococcal Vaccine Sales by Type
7.3 Europe 7-Valent Pneumococcal Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 7-Valent Pneumococcal Vaccine by Country
8.1.1 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Type
8.3 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 7-Valent Pneumococcal Vaccine
10.3 Manufacturing Process Analysis of 7-Valent Pneumococcal Vaccine
10.4 Industry Chain Structure of 7-Valent Pneumococcal Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 7-Valent Pneumococcal Vaccine Distributors
11.3 7-Valent Pneumococcal Vaccine Customer
12 World Forecast Review for 7-Valent Pneumococcal Vaccine by Geographic Region
12.1 Global 7-Valent Pneumococcal Vaccine Market Size Forecast by Region
12.1.1 Global 7-Valent Pneumococcal Vaccine Forecast by Region (2023-2028)
12.1.2 Global 7-Valent Pneumococcal Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 7-Valent Pneumococcal Vaccine Forecast by Type
12.7 Global 7-Valent Pneumococcal Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck 7-Valent Pneumococcal Vaccine Product Offered
13.1.3 Merck 7-Valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
14 Research Findings and Conclusion
Table 1. 7-Valent Pneumococcal Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. 7-Valent Pneumococcal Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global 7-Valent Pneumococcal Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global 7-Valent Pneumococcal Vaccine Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global 7-Valent Pneumococcal Vaccine Revenue by Application (2017-2022)
Table 13. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global 7-Valent Pneumococcal Vaccine Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global 7-Valent Pneumococcal Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global 7-Valent Pneumococcal Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global 7-Valent Pneumococcal Vaccine Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers 7-Valent Pneumococcal Vaccine Producing Area Distribution and Sales Area
Table 21. Players 7-Valent Pneumococcal Vaccine Products Offered
Table 22. 7-Valent Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global 7-Valent Pneumococcal Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global 7-Valent Pneumococcal Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global 7-Valent Pneumococcal Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global 7-Valent Pneumococcal Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global 7-Valent Pneumococcal Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas 7-Valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas 7-Valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas 7-Valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC 7-Valent Pneumococcal Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC 7-Valent Pneumococcal Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC 7-Valent Pneumococcal Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC 7-Valent Pneumococcal Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe 7-Valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe 7-Valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe 7-Valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of 7-Valent Pneumococcal Vaccine
Table 66. Key Market Challenges & Risks of 7-Valent Pneumococcal Vaccine
Table 67. Key Industry Trends of 7-Valent Pneumococcal Vaccine
Table 68. 7-Valent Pneumococcal Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. 7-Valent Pneumococcal Vaccine Distributors List
Table 71. 7-Valent Pneumococcal Vaccine Customer List
Table 72. Global 7-Valent Pneumococcal Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global 7-Valent Pneumococcal Vaccine Sales Market Forecast by Region
Table 74. Global 7-Valent Pneumococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global 7-Valent Pneumococcal Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas 7-Valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas 7-Valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC 7-Valent Pneumococcal Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC 7-Valent Pneumococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe 7-Valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe 7-Valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global 7-Valent Pneumococcal Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global 7-Valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global 7-Valent Pneumococcal Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global 7-Valent Pneumococcal Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global 7-Valent Pneumococcal Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global 7-Valent Pneumococcal Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global 7-Valent Pneumococcal Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global 7-Valent Pneumococcal Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, 7-Valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck 7-Valent Pneumococcal Vaccine Product Offered
Table 94. Merck 7-Valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
List of Figures
Figure 1. Picture of 7-Valent Pneumococcal Vaccine
Figure 2. 7-Valent Pneumococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 7-Valent Pneumococcal Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global 7-Valent Pneumococcal Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. 7-Valent Pneumococcal Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Type in 2021
Figure 12. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. 7-Valent Pneumococcal Vaccine Consumed in Hospital
Figure 14. Global 7-Valent Pneumococcal Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. 7-Valent Pneumococcal Vaccine Consumed in Clinic
Figure 16. Global 7-Valent Pneumococcal Vaccine Market: Clinic (2017-2022) & (K Units)
Figure 17. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Application in 2021
Figure 19. 7-Valent Pneumococcal Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Company in 2021
Figure 21. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas 7-Valent Pneumococcal Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas 7-Valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC 7-Valent Pneumococcal Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC 7-Valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe 7-Valent Pneumococcal Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe 7-Valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas 7-Valent Pneumococcal Vaccine Sales Market Share by Country in 2021
Figure 34. Americas 7-Valent Pneumococcal Vaccine Revenue Market Share by Country in 2021
Figure 35. United States 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC 7-Valent Pneumococcal Vaccine Sales Market Share by Region in 2021
Figure 40. APAC 7-Valent Pneumococcal Vaccine Revenue Market Share by Regions in 2021
Figure 41. China 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe 7-Valent Pneumococcal Vaccine Sales Market Share by Country in 2021
Figure 48. Europe 7-Valent Pneumococcal Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country 7-Valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of 7-Valent Pneumococcal Vaccine in 2021
Figure 62. Manufacturing Process Analysis of 7-Valent Pneumococcal Vaccine
Figure 63. Industry Chain Structure of 7-Valent Pneumococcal Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...